seed
Stage
1
Investors
About
StimOxyGen develops a pH-sensitive nanoparticle formulation that generates oxygen transiently in hypoxic solid tumors to improve the efficacy of cancer treatments such as radiotherapy and chemotherapy.
Explore StimOxyGen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.